A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial, with one of the candidates also matching Bristol Myers Squibb and Pfizer’s ...

In patients with atrial fibrillation (AF) with a recent episode of intracranial hemorrhage (ICH), the use of oral anticoagulants significantly reduced net adverse clinical events — primarily driven by ...

Anticoagulants are medications that help stop your blood from thickening or “clotting.” Your body does need to be able to clot to help seal wounds inside and outside your body. But unnecessary clots ...

Findings provide novel information on the risks and benefits of DOACs and warfarin for stroke prophylaxis in patients with AF according to BMI categories in a large general population cohort. normal ...

In the first randomized trial of stroke prevention after ischemic stroke in patients who have both nonvalvular atrial fibrillation (AF, Afib) and atherosclerosis, adding an antiplatelet to ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: Many members of my family and I have protein S deficiency ...

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. Contact ...

The anti-clotting drug warfarin, commonly known by the brand name Coumadin, is no longer recommended for the treatment of atrial fibrillation except for a select subset of patients, according to ...